ZNF440
gene geneOn this page
Also known as FLJ37933
Summary
ZNF440 (zinc finger protein 440, HGNC:20874) is a protein-coding gene on chromosome 19p13.2, encoding Zinc finger protein 440 (Q8IYI8). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.
Source: NCBI Gene 126070 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 107 total
- MANE Select transcript:
NM_152357
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20874 |
| Approved symbol | ZNF440 |
| Name | zinc finger protein 440 |
| Location | 19p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ37933 |
| Ensembl gene | ENSG00000171295 |
| Ensembl biotype | protein_coding |
| Entrez | 126070 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 5 protein_coding, 1 retained_intron
ENST00000304060, ENST00000414255, ENST00000427505, ENST00000457526, ENST00000587795, ENST00000588954
RefSeq mRNA: 1 — MANE Select: NM_152357
NM_152357
CCDS: CCDS42503
Canonical transcript exons
ENST00000304060 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001244043 | 11831368 | 11835216 |
| ENSE00001484873 | 11814273 | 11814450 |
| ENSE00003679566 | 11830283 | 11830409 |
| ENSE00003693605 | 11830617 | 11830677 |
Expression profiles
Bgee: expression breadth ubiquitous, 204 present calls, max score 91.68.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.5955 / max 124.4996, expressed in 1622 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 173968 | 7.5955 | 1622 |
Top tissues by expression
267 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 91.68 | gold quality |
| bronchial epithelial cell | CL:0002328 | 91.63 | gold quality |
| right uterine tube | UBERON:0001302 | 91.18 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.12 | gold quality |
| colonic epithelium | UBERON:0000397 | 85.98 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 85.77 | gold quality |
| bronchus | UBERON:0002185 | 85.00 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 83.71 | gold quality |
| skin of abdomen | UBERON:0001416 | 83.38 | gold quality |
| rectum | UBERON:0001052 | 82.66 | gold quality |
| skin of leg | UBERON:0001511 | 81.90 | gold quality |
| transverse colon | UBERON:0001157 | 80.79 | gold quality |
| calcaneal tendon | UBERON:0003701 | 80.73 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 80.37 | gold quality |
| zone of skin | UBERON:0000014 | 79.74 | gold quality |
| cortical plate | UBERON:0005343 | 79.68 | gold quality |
| esophagus mucosa | UBERON:0002469 | 79.67 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 78.54 | gold quality |
| body of pancreas | UBERON:0001150 | 78.03 | gold quality |
| minor salivary gland | UBERON:0001830 | 77.98 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 77.94 | gold quality |
| body of stomach | UBERON:0001161 | 77.81 | gold quality |
| right lung | UBERON:0002167 | 77.42 | gold quality |
| monocyte | CL:0000576 | 77.31 | gold quality |
| adrenal tissue | UBERON:0018303 | 77.21 | gold quality |
| skin of hip | UBERON:0001554 | 77.20 | gold quality |
| stomach | UBERON:0000945 | 77.17 | gold quality |
| ganglionic eminence | UBERON:0004023 | 77.13 | gold quality |
| leukocyte | CL:0000738 | 77.10 | gold quality |
| sural nerve | UBERON:0015488 | 77.09 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
116 targeting ZNF440, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-6867-5P | 100.00 | 82.21 | 3464 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-557 | 99.96 | 70.01 | 1640 |
| HSA-MIR-2110 | 99.96 | 66.68 | 1930 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-335-3P | 99.93 | 73.36 | 4958 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-4302 | 99.89 | 67.94 | 1187 |
| HSA-MIR-605-3P | 99.88 | 69.22 | 1833 |
| HSA-MIR-629-3P | 99.85 | 67.99 | 1875 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
Literature-anchored findings (GeneRIF, showing 1)
- Zinc finger protein-440 promotes cartilage degenerative mechanisms in human facet and knee osteoarthritis chondrocytes. (PMID:33347923)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp78 | ENSMUSG00000055150 |
| rattus_norvegicus | ENSRNOG00000083797 | |
| drosophila_melanogaster | CG2712 | FBGN0024975 |
| drosophila_melanogaster | Phs | FBGN0036522 |
| drosophila_melanogaster | CG3281 | FBGN0260741 |
Paralogs (62): ZNF582 (ENSG00000018869), ZNF264 (ENSG00000083844), ZNF343 (ENSG00000088876), ZNF684 (ENSG00000117010), ZNF133 (ENSG00000125846), ZNF557 (ENSG00000130544), ZNF337 (ENSG00000130684), ZNF20 (ENSG00000132010), ZFP37 (ENSG00000136866), ZNF614 (ENSG00000142556), KRBOX4 (ENSG00000147121), ZNF599 (ENSG00000153896), ZNF19 (ENSG00000157429), ZNF589 (ENSG00000164048), PRDM9 (ENSG00000164256), ZNF180 (ENSG00000167384), ZNF558 (ENSG00000167785), ZNF35 (ENSG00000169981), ZNF778 (ENSG00000170100), ZNF439 (ENSG00000171291), ZNF556 (ENSG00000172000), ZNF554 (ENSG00000172006), ZNF596 (ENSG00000172748), ZNF80 (ENSG00000174255), ZNF266 (ENSG00000174652), ZNF25 (ENSG00000175395), ZNF77 (ENSG00000175691), ZNF169 (ENSG00000175787), ZNF404 (ENSG00000176222), ZNF491 (ENSG00000177599), ZNF620 (ENSG00000177842), ZNF619 (ENSG00000177873), ZNF875 (ENSG00000181666), ZNF329 (ENSG00000181894), ZFP90 (ENSG00000184939), ZNF566 (ENSG00000186017), ZNF529 (ENSG00000186020), ZNF749 (ENSG00000186230), ZNF555 (ENSG00000186300), ZNF70 (ENSG00000187792)
Protein
Protein identifiers
Zinc finger protein 440 — Q8IYI8 (reviewed: Q8IYI8)
All UniProt accessions (5): C9J3D9, C9JG89, C9JV94, Q8IYI8, K7EJ55
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_689570* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096, PF01352, PF13894
UniProt features (19 total): zinc finger region 12, sequence variant 4, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8IYI8-F1 | 62.11 | 0.09 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 62 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, chr19p13, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN, ZWANG_DOWN_BY_2ND_EGF_PULSE, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, FOXJ2_TARGET_GENES, ZFHX3_TARGET_GENES, ZNF257_TARGET_GENES, ZNF410_TARGET_GENES, MIR4262, MIR6809_3P, MIR181A_5P_MIR181B_5P, MIR181D_5P, MIR181C_5P
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (6): RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| transcription cis-regulatory region binding | 1 |
| chromatin | 1 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
412 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF440 | MAFIP | Q8WZ33 | 621 |
| ZNF440 | OR6C4 | Q8NGE1 | 574 |
| ZNF440 | C19orf44 | Q9H6X5 | 475 |
| ZNF440 | CWF19L2 | Q2TBE0 | 432 |
| ZNF440 | CLCC1 | Q96S66 | 370 |
| ZNF440 | TMEM120B | A0PK00 | 365 |
| ZNF440 | DUS3L | Q96G46 | 358 |
| ZNF440 | EVC | P57679 | 290 |
| ZNF440 | HTR3E | A5X5Y0 | 290 |
| ZNF440 | SPATA22 | Q8NHS9 | 287 |
| ZNF440 | USP53 | Q70EK8 | 274 |
| ZNF440 | MTFMT | Q96DP5 | 270 |
| ZNF440 | TMPRSS11A | Q6ZMR5 | 269 |
| ZNF440 | LONP2 | Q86WA8 | 250 |
| ZNF440 | J3KSM2 | J3KSM2 | 248 |
IntAct
116 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MDFI | ZNF440 | psi-mi:“MI:0915”(physical association) | 0.880 |
| ZNF440 | MDFI | psi-mi:“MI:0915”(physical association) | 0.880 |
| ZNF440 | TRAF1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| TRAF1 | ZNF440 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZNF440 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MID2 | ZNF440 | psi-mi:“MI:0915”(physical association) | 0.720 |
| KRTAP10-9 | ZNF440 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF440 | MID2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZNF440 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF440 | NOTCH2NLA | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF440 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| NOTCH2NLA | ZNF440 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF440 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (52): ZNF440 (Two-hybrid), ZNF440 (Two-hybrid), ZNF440 (Two-hybrid), ZNF440 (Two-hybrid), KRTAP10-9 (Two-hybrid), KRTAP10-1 (Two-hybrid), NOTCH2NL (Two-hybrid), ZNF440 (Two-hybrid), ZNF440 (Two-hybrid), CCNDBP1 (Two-hybrid), MDFI (Two-hybrid), TRAF1 (Two-hybrid), ZNF440 (Two-hybrid), ZNF440 (Affinity Capture-RNA), MDFI (Two-hybrid)
ESM2 similar proteins: A0A1W2PQL4, A2RRD8, A6NHJ4, B4DX44, O75346, O95780, P0CB33, P15621, P21506, P51508, P51814, Q0VGE8, Q15928, Q15973, Q2M218, Q2M3X9, Q3KNS6, Q3MIS6, Q3SXZ3, Q494X3, Q5HY98, Q5RBQ3, Q5RCJ2, Q5RER9, Q5VIY5, Q6J6I6, Q6ZMW2, Q7L2R6, Q86XU0, Q86Y25, Q8IYI8, Q8IYN0, Q8IYX0, Q8N184, Q8N782, Q8N823, Q8N9Z0, Q8NB42, Q8NDP4, Q8NEP9
Diamond homologs: A0JPK3, A8MT65, C9JN71, E9QAG8, G3X9G7, O75820, P16373, P16374, P16415, P17017, P17024, P17025, P51815, P52737, Q08AG5, Q08ER8, Q0D2J5, Q15973, Q2M218, Q3KP31, Q3V080, Q494X3, Q4R4C7, Q5MYW4, Q5R9F0, Q5R9S5, Q5REI6, Q5REK1, Q68EA5, Q6P560, Q6P5C7, Q6ZQV5, Q7L945, Q86T29, Q8BGV5, Q8C6P8, Q8IYI8, Q8IZC7, Q8N7K0, Q8N972
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 36 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Keratinization | 13 | 29.0× | 4e-15 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
107 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 83 |
| Likely benign | 14 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
817 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:11814437:G:GT | donor_gain | 1.0000 |
| 19:11830267:ATGT:A | acceptor_gain | 1.0000 |
| 19:11830268:T:G | acceptor_gain | 1.0000 |
| 19:11831357:A:AG | acceptor_gain | 1.0000 |
| 19:11831358:T:G | acceptor_gain | 1.0000 |
| 19:11831363:GACA:G | acceptor_loss | 1.0000 |
| 19:11831365:CA:C | acceptor_loss | 1.0000 |
| 19:11831366:A:AG | acceptor_gain | 1.0000 |
| 19:11831366:A:AT | acceptor_loss | 1.0000 |
| 19:11831366:AG:A | acceptor_gain | 1.0000 |
| 19:11831367:G:GA | acceptor_gain | 1.0000 |
| 19:11831367:GG:G | acceptor_gain | 1.0000 |
| 19:11831367:GGA:G | acceptor_gain | 1.0000 |
| 19:11831367:GGAGT:G | acceptor_gain | 1.0000 |
| 19:11814437:G:T | donor_gain | 0.9900 |
| 19:11814451:G:GG | donor_gain | 0.9900 |
| 19:11814452:T:A | donor_loss | 0.9900 |
| 19:11830265:A:AG | acceptor_gain | 0.9900 |
| 19:11830265:ACAT:A | acceptor_gain | 0.9900 |
| 19:11830266:C:G | acceptor_gain | 0.9900 |
| 19:11830267:AT:A | acceptor_gain | 0.9900 |
| 19:11830268:T:TA | acceptor_gain | 0.9900 |
| 19:11830270:T:TA | acceptor_gain | 0.9900 |
| 19:11830409:GGT:G | donor_loss | 0.9900 |
| 19:11830410:G:GC | donor_loss | 0.9900 |
| 19:11830410:G:GG | donor_gain | 0.9900 |
| 19:11830411:T:A | donor_loss | 0.9900 |
| 19:11830673:TTCAG:T | donor_loss | 0.9900 |
| 19:11830674:TCAGG:T | donor_loss | 0.9900 |
| 19:11830675:CAG:C | donor_loss | 0.9900 |
AlphaMissense
3968 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:11832389:T:C | F405L | 0.992 |
| 19:11832391:C:A | F405L | 0.992 |
| 19:11832391:C:G | F405L | 0.992 |
| 19:11832473:T:C | F433L | 0.992 |
| 19:11832475:C:A | F433L | 0.992 |
| 19:11832475:C:G | F433L | 0.992 |
| 19:11832575:T:C | F467L | 0.991 |
| 19:11832577:T:A | F467L | 0.991 |
| 19:11832577:T:G | F467L | 0.991 |
| 19:11832305:T:C | F377L | 0.984 |
| 19:11832307:C:A | F377L | 0.984 |
| 19:11832307:C:G | F377L | 0.984 |
| 19:11832395:T:C | S407P | 0.980 |
| 19:11832418:T:A | H414Q | 0.979 |
| 19:11832418:T:G | H414Q | 0.979 |
| 19:11832390:T:C | F405S | 0.978 |
| 19:11832408:T:C | L411P | 0.977 |
| 19:11832430:C:A | H418Q | 0.976 |
| 19:11832430:C:G | H418Q | 0.976 |
| 19:11830317:T:C | F13S | 0.975 |
| 19:11830316:T:C | F13L | 0.974 |
| 19:11830318:C:A | F13L | 0.974 |
| 19:11830318:C:G | F13L | 0.974 |
| 19:11832416:C:G | H414D | 0.974 |
| 19:11831885:T:C | F237L | 0.969 |
| 19:11831887:T:A | F237L | 0.969 |
| 19:11831887:T:G | F237L | 0.969 |
| 19:11831801:T:C | F209L | 0.966 |
| 19:11831803:C:A | F209L | 0.966 |
| 19:11831803:C:G | F209L | 0.966 |
dbSNP variants (sampled 300 via entrez): RS1000153301 (19:11821230 G>A), RS1000821042 (19:11831708 G>A), RS1000863354 (19:11820607 AG>A), RS1000926537 (19:11816483 G>A), RS1000983691 (19:11815434 A>G), RS1001310542 (19:11820419 C>T), RS1001488313 (19:11834285 C>T), RS1001510221 (19:11818479 C>T), RS1001545305 (19:11816238 G>A), RS1001719240 (19:11813273 C>A), RS1001875210 (19:11831345 A>G), RS1001879011 (19:11814825 C>G), RS1002084839 (19:11813685 A>C), RS1002197218 (19:11825386 A>G,T), RS1002293125 (19:11828845 C>G,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004521_294 | Autism spectrum disorder or schizophrenia | 5.000000e-08 |
| GCST90002407_363 | White blood cell count | 8.000000e-11 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
19 total (human), top 19 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression | 3 |
| TAK-243 | increases sumoylation | 1 |
| dicrotophos | decreases expression | 1 |
| resorcinol | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Lead | affects expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Quercetin | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Okadaic Acid | increases expression | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.